Year : 2023
PSGL-1 attenuates early TCR signaling to suppress CD8+ T cell progenitor differentiation and elicit terminal CD8+ T cell exhaustion
Cite this Research Publication : Hope, J.L., Otero, D., Bae, E., Stairiker, C.J., Palete, A.B., Faso, H.A., Lin, M., Henriquez, M.L., Roy, S., Seo, H., Lei, X., Wang, E.S., Chow, S., Tinoco, R., Daniels, G.A., Yip, K., Campos, A.R., Yin, J., Adams, P.D., Rao, A., and Bradley, L.M. PSGL-1 attenuates early TCR signaling to suppress CD8+ T cell progenitor differentiation and elicit terminal CD8+ T cell exhaustion. Cell Reports. 2023
Publisher : Cell Reports
Year : 2022
Lung group 2 innate lymphoid cells as a new adjuvant target to enhance intranasal vaccine efficacy against influenza
Cite this Research Publication : Williams, C.M., Roy, S., Sun, W., Furuya, A.M., Wijesundara, D.K., Furuya, Y. Lung group 2 innate lymphoid cells as a new adjuvant target to enhance intranasal vaccine efficacy against influenza. Clin Trans Immunol. 2022
Publisher : Clin Trans Immunol
Year : 2022
Evaluation of Innate Lymphoid Cells and Dendritic Cells Following Viral Vector Vaccination. In: Brun, A. (eds) Vaccine Technologies for Veterinary Viral Diseases
Cite this Research Publication : Li, Z., Roy, S., and Ranasinghe, C. (2022). Evaluation of Innate Lymphoid Cells and Dendritic Cells Following Viral Vector Vaccination. In: Brun, A. (eds) Vaccine Technologies for Veterinary Viral Diseases. Methods in Molecular Biology, vol 2465. Humana, New York, NY
Publisher : Humana
Year : 2021
IL-13Rα2 Regulates the IL-13/IFN-γ Balance during Innate Lymphoid Cell and Dendritic Cell Responses to Pox Viral Vector-Based Vaccination
Cite this Research Publication : Li, Z., Roy, S., and Ranasinghe, C. IL-13Rα2 Regulates the IL-13/IFN-γ Balance during Innate Lymphoid Cell and Dendritic Cell Responses to Pox Viral Vector-Based Vaccination. Vaccines. 2021
Publisher : Vaccines
Year : 2021
STAT3 determines IL-4 signalling outcomes in naïve T cells
Cite this Research Publication : Deimel, L.P., Li, Z., Roy, S.,and Ranasinghe, C. STAT3 determines IL-4 signalling outcomes in naïve T cells.Scientific Reports. 2021
Publisher : Scientific Reports
Year : 2021
Detrimental impact of allergic airway disease on live attenuated influenza vaccine
Cite this Research Publication : Roy, S., Williams, C.M., and Furuya, Y. Detrimental impact of allergic airway disease on live attenuated influenza vaccine. Health Science Reports. 2021
Publisher : Health Science Reports
Year : 2021
IL-33-ILC2 axis represents a potential adjuvant target to increase the cross-protective efficacy of influenza vaccine
Cite this Research Publication : Williams, C.M., Roy, S., Califano, D., McKenzie, A.N.J., Metzger, D.W., and Furuya,Y. IL-33-ILC2 axis represents a potential adjuvant target to increase the cross-protective efficacy of influenza vaccine. J. Virol. 2021
Publisher : J. Virol.
Year : 2020
A Triple-challenge Mouse Model of Allergic Airway Disease, Primary Influenza Infection, and Secondary Bacterial Infection
Cite this Research Publication : Roberts, S., Williams M.C., Roy, S*., Furuya, Y. A Triple-challenge Mouse Model of Allergic Airway Disease, Primary Influenza Infection, and Secondary Bacterial Infection. Bio-Protocol 2020
Publisher : Bio-Protocol
Year : 2020
Impact of pre-existing immunity on live attenuated influenza vaccine-induced cross-protective immunity
Cite this Research Publication : Roy, S., Williams, M.C., Pardo, J., Wijesundara, D.K., and Furuya, Y. Impact of pre-existing immunity on live attenuated influenza vaccine-induced cross-protective immunity. Vaccines 2020
Publisher : Vaccines
Year : 2020
Impact of pre-existing immunity to influenza on live attenuated influenza vaccine (LAIV) immunogenicity
Cite this Research Publication : Roy, S.,Williams, M.C., Wijesundara, D.K., and Furuya, Y. Impact of pre-existing immunity to influenza on live attenuated influenza vaccine (LAIV) immunogenicity. Vaccines 2020
Publisher : Vaccines
Year : 2020
Unique IL-13Rα2/STAT3 mediated IL-13 regulation detected in lung conventional dendritic cells, 24 h post viral vector vaccination
Cite this Research Publication : Roy, S., Liu, H., Jaeson, M.I., Deimel, L.P., and Ranasinghe, C. Unique IL-13Rα2/STAT3 mediated IL-13 regulation detected in lung conventional dendritic cells, 24 h post viral vector vaccination. Scientific Reports2020
Publisher : Scientific Reports
Year : 2019
Viral vector and route of administration determine the ILC and DC profiles responsible for downstream vaccine-specific immune outcomes
Cite this Research Publication : Roy, S., Mahboob, S., Li, Z., Jaeson, M.I., Jackson, J.R., Grubor-Bauk, B., Wijesundara, D.K., Gowans E.J., and Ranasinghe, C. Viral vector and route of administration determine the ILC and DC profiles responsible for downstream vaccine-specific immune outcomes. Vaccine 2019
Publisher : Vaccine
Year : 2018
Unexpected Involvement of IL-13 Signalling via a STAT6 Independent Mechanism, During IgG2a Development Following Viral Vaccination
Cite this Research Publication : Hamid, M.A.*, Jackson, J.R.*, Roy, S*, Khanna, M., and Ranasinghe, C. Unexpected Involvement of IL-13 Signalling via a STAT6 Independent Mechanism, During IgG2a Development Following Viral Vaccination. Eur J Immunol. 2018
Publisher : Eur J Immunol
Year : 2015
Monitoring and cell-specific deletion of C5aR1 using a novel floxed GFP-C5aR1 reporter knock-in mouse
Cite this Research Publication : Karsten, C.M., Laumonnier, Y., Eurich, B., Ender, F., Bröker, K., Roy, S., Czabanska, A., Vollbrandt, T., Figge, J., and Köhl, J. Monitoring and cell-specific deletion of C5aR1 using a novel floxed GFP-C5aR1 reporter knock-in mouse. J. Immunol.2015
Publisher : J. Immunol